Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: A pilot study including electrophysiology

Neurorehabilitation and Neural Repair

Volumn 25, Issue 6, 2011, Pages 512-520

  Falsini, Benedetto ^a   Chiaretti, Antonio ^a   Barone, Giuseppe ^a   Piccardi, Marco ^a   Pierri, Filomena ^a   Colosimo, Cesare ^a   Lazzareschi, Ilaria ^a   Ruggiero, Antonio ^a   Parisi, Vincenzo ^b   Fadda, Antonello ^c   Balestrazzi, Emilio ^a   Riccardi, Riccardo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

nerve growth factor; optic gliomas; retinal ganglion cells; visual evoked potentials; visual function rescue

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CARBOPLATIN; DEXAMETHASONE; EYE DROPS; LOMUSTINE; NERVE GROWTH FACTOR; PROCARBAZINE; VINCRISTINE;

ACUTE INTRATUMOR HEMORRHAGIC INFARCTION; ADOLESCENT; ADULT; ALLERGIC REACTION; ARTICLE; BIOMICROSCOPY; CANCER CHEMOTHERAPY; CATARACT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CYCLITIS; DRUG EFFICACY; DRUG SAFETY; EVOKED VISUAL RESPONSE; EYE PAIN; FEMALE; FOLLOW UP; HUMAN; INFARCTION; INTRACRANIAL PRESSURE; INTRAOCULAR PRESSURE; IRIS INFLAMMATION; MAINTENANCE THERAPY; MALE; NEUROFIBROMATOSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OPTIC NERVE ATROPHY; OPTIC NERVE GLIOMA; OUTCOME ASSESSMENT; PILOT STUDY; RETINA GANGLION CELL; SENSORY SYSTEM ELECTROPHYSIOLOGY; SIDE EFFECT; TEST RETEST RELIABILITY; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR VOLUME; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANIMALS; BLINDNESS; CHILD; CHILD, PRESCHOOL; ELECTRODIAGNOSIS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MICE; NERVE GROWTH FACTOR; NERVE REGENERATION; OPTIC NERVE; OPTIC NERVE GLIOMA; PILOT PROJECTS; VISUAL PATHWAYS;

EID: 79959298367     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/1545968310397201     Document Type: Article

References (43)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987 ; 874: 1154-1162 (Pubitemid 17124912)
2. DeKosky ST, Taffe KM, Abrahamson EE, Dixon CE, Kochanek PM, Ikonomovic MD. Time course analysis of hippocampal nerve growth factor and antioxidant enzyme activity following lateral controlled cortical impact brain injury in the rat. J Neurotrauma. 2004 ; 21: 491-500 (Pubitemid 38656747)
3. Verge VM, Merlio JP, Grondin J, et al. Colocalization of NGF binding sites, trkA mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF. J Neurosci. 1992 ; 12: 4011-4022
4. Chiaretti A, Barone G, Riccardi R, et al. NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children. Neurology. 2009 ; 72: 609-616
5. Mufson EJ, Kroin JS, Sendera TJ, Sobreviela T. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Prog Neurobiol. 1999 ; 57: 451-484 (Pubitemid 29057112)
6. Kordower JH, Isacson O, Leventhal L, Emerich DF. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?. Prog Brain Res. 2000 ; 127: 414-430
7. Eriksdotter Jönhagen M, Nordberg A, Amberla K, et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 1998 ; 9: 246-257 (Pubitemid 28377225)
8. Olson L, Backlund EO, Ebendal T, et al. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch Neurol. 1991 ; 48: 373-381
9. Chiaretti A, Antonelli A, Genovese O, et al. Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic-ischemic brain injury. Neurol Res. 2008 ; 30: 223-228 (Pubitemid 351769412)
10. Chiaretti A, Genovese O, Riccardi R, et al. Intraventricular nerve growth factor infusion: a possible treatment for neurological deficits following hypoxic-ischemic brain injury in infants. Neurol Res. 2005 ; 27: 741-746 (Pubitemid 41513083)
11. Micera A, Lambiase A, Aloe L, Bonini S, Levi-Schaffer F, Bonini S. Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev. 2004 ; 15: 411-417 (Pubitemid 39550452)
12. Carmignoto G, Comelli MC, Candeo P, et al. Expression of NGF receptor mRNA in the developing and adult rat retina. Exp Neurobiol. 1991 ; 111: 302-311
13. Caleo M, Menna E, Chierzi S, Cenni MC, Maffei L. Brain-derived neurotrophic factor is an anterograde survival factor in the rat visual system. Curr Biol. 2000 ; 10: 1155-1161
14. Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci. 1989 ; 9: 1263-1272 (Pubitemid 19116746)
15. Siliprandi R, Canella R, Carmignoto G. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci. 1993 ; 34: 3232-3245 (Pubitemid 23346655)
16. Tuszynski MH, Roberts J, Senut MC, U HS, Gage FH. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther. 1996 ; 3: 305-314
17. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med. 1998 ; 338: 1174-1180 (Pubitemid 28180745)
18. Lambiase A, Aloe L, Centofanti M, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc Nat Acad Sci U S A. 2009 ; 106: 13469-13474
19. Lambiase A, Tirassa P, Micera A, Aloe L, Bonini S. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci. 2005 ; 46: 3800-3806 (Pubitemid 44264689)
20. Packer RJ, Lange B, Ater J, et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol. 1993 ; 11: 850-856 (Pubitemid 23146078)
21. Trisciuzzi MT, Riccardi R, Piccardi M, et al. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol. 2004 ; 11: 217-226 (Pubitemid 38045617)
22. Falsini B, Ziccardi L, Lazzareschi I, et al. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J Neurooncol. 2008 ; 88: 87-96
23. Fadda A, Falsini B, Neroni M, Porciatti V. Development of personal computer software for a visual electrophysiology laboratory. Comput Methods Programs Biomed. 1989 ; 28: 45-50 (Pubitemid 19032045)
24. Marmor MF. An international standard for electroretinography. Doc Ophthalmol. 1989 ; 73: 299-302 (Pubitemid 20166926)
25. Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30,000 molecular weight protein. Proc Natl Acad Sci U S A. 1969 ; 64: 787-794
26. McArthur JC, Yiannoutsos C, Simpson DM, et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology. 2000 ; 54: 1080-1088 (Pubitemid 30151849)
27. Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA. 2000 ; 284: 2215-2221
28. Lambiase A, Pagani L, Di Fausto V, et al. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res. 2007 ; 1127: 45-51 (Pubitemid 44873000)
29. Zar JH Biostatistical Analysis. Zar JH, ed. Englewood Cliffs, NJ: Prentice Hall ; 1974: 310-328.
30. Parsa CF, Hoyt CS, Lesser RL, et al. Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging. Arch Ophthalmol. 2001 ; 119: 516-529 (Pubitemid 32290060)
31. Coassin M, Lambiase A, Sposato V, Micera A, Bonini S, Aloe L. Retinal p75 and bax over expression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefes Arch Clin Exp Ophthalmol. 2008 ; 246: 1743-1749
32. Ia Sala A, Corinti S, Federici M, Saragovi HU, Girolomoni G. Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis. J Leukoc Biol. 2000 ; 68: 104-110
33. Lambiase A, Centofanti M, Micera A, et al. Nerve growth factor (NGF) and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 1997 ; 235: 780-785 (Pubitemid 27514275)
34. Pizzorusso T, Porciatti V, Tseng JL, Aebischer P, Maffei L. Transplant of polymered capsulated cells genetically engineered to release nerve growth factor allows a normal functional development of the visual cortex in dark-reared rats. Neuroscience. 1997 ; 80: 307-311 (Pubitemid 27334582)
35. Lodovichi C, Berardi N, Pizzorusso T, Maffei L. Effects of neurotrophins on cortical plasticity: same or different?. J Neurosci. 2000 ; 20: 2155-2165 (Pubitemid 30230068)
36. Rohrer B, Korenbrot JI, LaVail MM, Reichardt LF, Xu B. Role of neurotrophin receptor TrkB in the maturation of rod photoreceptors and establishment of synaptic transmission to the inner retina. J Neurosci. 1999 ; 19: 8919-8930 (Pubitemid 30226713)
37. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci. 1986 ; 6: 2155-2162 (Pubitemid 16043658)
38. Shimohama S, Ogawa N, Tamura Y, et al. Protective effect of nerve growth factor against glutamate induced neurotoxicity in cultured cortical neurons. Brain Res. 1993 ; 632: 296-302 (Pubitemid 24015528)
39. Lu B. Acute and long-term synaptic modulation by neurotrophins. Prog Brain Res. 2004 ; 146: 137-150 (Pubitemid 37541381)
40. Sofroniew MV, Howe CL, Moblley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001 ; 24: 1217-1281 (Pubitemid 32695259)
41. Lenzi L, Coassin M, Lambiase A, Bonini S, Amendola T, Aloe L. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res. 2005 ; 45: 1491-1500 (Pubitemid 40386723)
42. Frost DO. BDNF/trkB signaling in the developmental sculpting of visual connections. Prog Brain Res. 2001 ; 134: 35-49
43. Chen H, Weber AJ. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci. 2001 ; 42: 966-974 (Pubitemid 32289791)